Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1982 Dec 31;68(6):527-30.

Randomized Trial of Chemoimmunotherapy in Advanced Non-Oat-Cell Lung Cancer

  • PMID: 6762741
Clinical Trial

Randomized Trial of Chemoimmunotherapy in Advanced Non-Oat-Cell Lung Cancer

R Rosso et al. Tumori. .

Abstract

Thirty patients without any prior chemotherapy and histologically proved non-oat-cell advanced lung cancer entered a randomized trial comparing a combination chemotherapeutic regimen (cyclophosphamide, methotrexate, BCNU) and the same combination plus intradermic BCG. Twenty-nine patients were evaluable for survival. Mean survival was 11 and 3.5 months for chemotherapy and chemoimmunotherapy group, respectively. The difference was statistically significant (P less than 0.025). A tumor enhancement can be postulated. Skin tests before treatment (PPD, Candida, Varidase) seem to be prognostic for survival.

Similar articles

See all similar articles
Feedback